PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
147.06%
Some net income increase while AVGO is negative at -9.78%. John Neff would see a short-term edge over the struggling competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-107.37%
Both negative yoy, with AVGO at -33.99%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-97.71%
Negative yoy CFO while AVGO is 7.23%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
31.03%
Some CapEx rise while AVGO is negative at -44.00%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-75.00%
We reduce yoy sales while AVGO is 333.33%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-1200.00%
We reduce yoy invests while AVGO stands at 23.56%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
100.00%
Debt repayment 1.25-1.5x AVGO's 89.41%. Bruce Berkowitz would see an edge in lowering interest burdens unless competitor invests in profitable expansions.
-100.00%
Negative yoy issuance while AVGO is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
5.33%
We have some buyback growth while AVGO is negative at -107.07%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.